Endothelin-1 and Endothelin Receptor mRNA Expression in Normal and Atherosclerotic Human Arteries
View/ Open
Winkles_Endothelin-1AndEndothelinReceptormRNAExpressionInNormalAndAtheroscleroticHumanArteries_BiochemBiophysResCommun_1993.pdf (496.4Kb)
Access Status
Full text of the requested work is not available in DASH at this time ("restricted access"). For more information on restricted deposits, see our FAQ.Published Version
https://doi.org/10.1006/bbrc.1993.1327Metadata
Show full item recordCitation
Winkles, J.A., G.F. Alberts, E. Brogi, and P. Libby. 1993. “Endothelin-1 and Endothelin Receptor mRNA Expression in Normal and Atherosclerotic Human Arteries.” Biochemical and Biophysical Research Communications 191 (3) (March): 1081–1088. doi:10.1006/bbrc.1993.1327.Abstract
Endothelin-1 (ET-1) is a potent vasoconstrictor peptide implicated in a number of human diseases including atherosclerosis. ET-1 binds to two distinct G protein-coupled receptors, known as the ETA and ETB receptor subtypes. In this study, we have examined ET-l, ETA and ETB mRNA expression levels in human vascular cells cultured in vitro and in normal and atherosclerotic human arteries. The results indicate that (a) ET-1 mRNA is constitutively expressed by endothelial cells but not by smooth muscle cells, (b) endothelial cells express only ETB mRNA but smooth muscle cells co-express ETA and ETB mRNA, and (c) in comparison to normal aorta, ET-l mRNA expression is elevated and endothelin receptor mRNA expression is repressed in atherosclerotic lesions.Citable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:35141005
Collections
- HMS Scholarly Articles [17922]
Contact administrator regarding this item (to report mistakes or request changes)